Syngenta Canada launched Clariva pn seed treatment

Syngenta Canada Inc. recently announced the registration and launch of Clariva™ pn seed treatment (Pasteuria nishizawae bacteria), an innovative, new biological seed treatment that provides growers with an important tool in the management of soybean cyst nematode (SCN).

“Clariva pn treated soybean seeds will take current SCN management programs to the next level by reducing SCN feeding and reproduction,” explains Nathan Klages, Seedcare and Inoculants Product Lead with Syngenta Canada. “This is a targeted, direct and proven solution that will help growers increase yields under SCN pressure.”

Clariva pn contains the Pasteuria nishizawae bacteria as its active ingredient. When Clariva pn treated seed is planted, the P. nishizawae spores are released into the soil and establish a protective zone around the young soybean plant’s roots.

The P. nishizawae spores infect and eventually kill SCN that come into contact with plant roots by curbing their ability to feed and reproduce. As the remnants of the nematodes decompose, the spores are released back into the soil to provide season-long activity and suppression.

Clariva pn is highly effective under variable environmental conditions, independent of soil pH, temperature or moisture.

Klages notes that Clariva pn supports crop rotation practices and complements the use of SCN resistant or partially resistant soybean varieties. “Until now, the most common method of managing SCN has been to select soybean varieties with resistance to the pest,” explains Klages. “However, a shift in the virulence of SCN means growers require additional management tools – and Clariva pn fills that need.”

Clariva pn is compatible with Cruiser Maxx® Vibrance® Beans and Vibrance Maxx seed treatments. Growers will be able to order Clariva pn on seed treated with either of these treatments from select companies and downstream treaters.